1. Home
  2. EYEN vs SPRC Comparison

EYEN vs SPRC Comparison

Compare EYEN & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYEN
  • SPRC
  • Stock Information
  • Founded
  • EYEN 2014
  • SPRC 2004
  • Country
  • EYEN United States
  • SPRC Israel
  • Employees
  • EYEN N/A
  • SPRC N/A
  • Industry
  • EYEN Biotechnology: Pharmaceutical Preparations
  • SPRC Biotechnology: Pharmaceutical Preparations
  • Sector
  • EYEN Health Care
  • SPRC Health Care
  • Exchange
  • EYEN Nasdaq
  • SPRC Nasdaq
  • Market Cap
  • EYEN 2.9M
  • SPRC 3.4M
  • IPO Year
  • EYEN 2018
  • SPRC N/A
  • Fundamental
  • Price
  • EYEN $4.88
  • SPRC $0.31
  • Analyst Decision
  • EYEN Hold
  • SPRC
  • Analyst Count
  • EYEN 4
  • SPRC 0
  • Target Price
  • EYEN $2.00
  • SPRC N/A
  • AVG Volume (30 Days)
  • EYEN 7.1M
  • SPRC 302.0K
  • Earning Date
  • EYEN 05-19-2025
  • SPRC 02-15-2025
  • Dividend Yield
  • EYEN N/A
  • SPRC N/A
  • EPS Growth
  • EYEN N/A
  • SPRC N/A
  • EPS
  • EYEN N/A
  • SPRC N/A
  • Revenue
  • EYEN $67,063.00
  • SPRC $1,306,000.00
  • Revenue This Year
  • EYEN $7,680.45
  • SPRC N/A
  • Revenue Next Year
  • EYEN $315.38
  • SPRC N/A
  • P/E Ratio
  • EYEN N/A
  • SPRC N/A
  • Revenue Growth
  • EYEN 663.82
  • SPRC N/A
  • 52 Week Low
  • EYEN $0.85
  • SPRC $0.20
  • 52 Week High
  • EYEN $124.80
  • SPRC $1.79
  • Technical
  • Relative Strength Index (RSI)
  • EYEN 86.35
  • SPRC 50.15
  • Support Level
  • EYEN $1.62
  • SPRC $0.30
  • Resistance Level
  • EYEN $2.30
  • SPRC $0.33
  • Average True Range (ATR)
  • EYEN 0.53
  • SPRC 0.02
  • MACD
  • EYEN 0.27
  • SPRC -0.00
  • Stochastic Oscillator
  • EYEN 79.17
  • SPRC 58.82

About EYEN Eyenovia Inc.

Eyenovia Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or new combinations.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: